| Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells W Yan, X Wu, W Zhou, MY Fong, M Cao, J Liu, X Liu, CH Chen, O Fadare, ... Nature cell biology 20 (5), 597-609, 2018 | 388 | 2018 |
| Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients C Yau, M Osdoit, M van der Noordaa, S Shad, J Wei, D de Croze, ... The Lancet Oncology 23 (1), 149-160, 2022 | 319 | 2022 |
| A proteogenomic portrait of lung squamous cell carcinoma S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ... Cell 184 (16), 4348-4371. e40, 2021 | 264 | 2021 |
| High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations R Murali, B Davidson, O Fadare, JA Carlson, CP Crum, CB Gilks, JA Irving, ... International Journal of Gynecological Pathology 38, S40-S63, 2019 | 255 | 2019 |
| Examination of low ERBB2 protein expression in breast cancer tissue AI Fernandez, M Liu, A Bellizzi, J Brock, O Fadare, K Hanley, M Harigopal, ... JAMA oncology 8 (4), 607-610, 2022 | 254 | 2022 |
| Tuberous sclerosis–associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients J Guo, MS Tretiakova, ML Troxell, AO Osunkoya, O Fadare, AR Sangoi, ... The American journal of surgical pathology 38 (11), 1457-1467, 2014 | 253 | 2014 |
| The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma W Zheng, X Yi, O Fadare, SX Liang, M Martel, PE Schwartz, Z Jiang The American journal of surgical pathology 32 (2), 304-315, 2008 | 244 | 2008 |
| Tubal origin of ‘ovarian’low-grade serous carcinoma J Li, N Abushahin, S Pang, L Xiang, SK Chambers, O Fadare, B Kong, ... Modern Pathology 24 (11), 1488-1499, 2011 | 219 | 2011 |
| Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis J Li, O Fadare, L Xiang, B Kong, W Zheng Journal of hematology & oncology 5, 1-11, 2012 | 199 | 2012 |
| Association of event-free and distant recurrence–free survival with individual-level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer … D Yee, AM DeMichele, C Yau, C Isaacs, WF Symmans, KS Albain, ... JAMA oncology 6 (9), 1355-1362, 2020 | 172 | 2020 |
| Age dependent association of endometrial polyps with increased risk of cancer involvement D Hileeto, O Fadare, M Martel, W Zheng World journal of surgical oncology 3, 1-6, 2005 | 168 | 2005 |
| Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal" PEComatosis": A clinicopathological study with comparative genomic … O Fadare, V Parkash, Y Yilmaz, MR Mariappan, L Ma, D Hileeto, ... World journal of surgical oncology 2, 1-12, 2004 | 164 | 2004 |
| Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases AM Burga, O Fadare, RA Lininger, FA Tavassoli Virchows Archiv 449, 507-512, 2006 | 155 | 2006 |
| Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology R Dewar, O Fadare, H Gilmore, AM Gown Archives of pathology & laboratory medicine 135 (4), 422-429, 2011 | 147 | 2011 |
| Perivascular epithelioid cell tumor (PEComa) of the uterus: an outcome-based clinicopathologic analysis of 41 reported cases O Fadare Advances in anatomic pathology 15 (2), 63-75, 2008 | 145 | 2008 |
| Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement O Fadare, V Parkash, ML Carcangiu, P Hui Modern Pathology 19 (1), 75-82, 2006 | 124 | 2006 |
| Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: a clinicopathologic study of 18 cases O Fadare, F Dadmanesh, I Alvarado-Cabrero, R Snyder, JS Mitchell, T Tot, ... The American journal of surgical pathology 30 (11), 1445-1453, 2006 | 121 | 2006 |
| Clinical and pathologic aspects of basal-like breast cancers O Fadare, FA Tavassoli Nature Clinical Practice Oncology 5 (3), 149-159, 2008 | 120 | 2008 |
| A proposed model for endometrial serous carcinogenesis W Zheng, L Xiang, O Fadare, B Kong The American journal of surgical pathology 35 (1), e1-e14, 2011 | 119 | 2011 |
| Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer ES Reisenbichler, G Han, A Bellizzi, V Bossuyt, J Brock, K Cole, O Fadare, ... Modern pathology 33 (9), 1746-1752, 2020 | 118 | 2020 |
